IBA to produce radiopharmaceuticals in Dallas

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Ion Beam Applications (IBA) has opened a new PET radiopharmaceutical production facility in Dallas, to serve PET imaging centers throughout Texas, Oklahoma and Arkansas.

The new facility is the latest addition to the IBA distribution network, supported by 47 PET radiopharmaceuticals production centers globally, of which 17 are located in North America, according to Pierre Mottet, CEO of the Louvain-la-Neuve, Belgium-based IBA.